Caution: Lose more than weight with imported diet pills

January 26, 2009

Americans who use illegal diet pills from South America are taking amphetamines without knowing it and seriously risking both their health and their jobs. Physicians need to be made aware of the range of serious side effects of these drugs to allow them to identify and treat those patients presenting with unexplained symptoms. These findings1, by Dr Pieter Cohen from the Department of Internal Medicine at the Cambridge Health Alliance in the US and Harvard Medical School, have recently been published online in Springer's Journal of General Internal Medicine.

Although the US Food and Drug Administration (FDA) has banned the majority of amphetamine-based appetite suppressants, many are still prescribed in other parts of the world, including South America. The second most often prescribed amphetamine-based appetite suppressant worldwide is fenproporex. It is known to be addictive and is rapidly converted into amphetamine in the body. The international availability of fenproporex, combined with Internet sales and other illegal markets, have led to its availability in the US, despite an FDA ban. Most physicians in the US are unaware of the existence of these diet pills combining fenproporex and benzodiazepines, selective serotonin reuptake inhibitors, diuretics, laxatives, thyroid hormones and other substances.

To illustrate the risks posed by taking these diet pills, Dr Cohen reviews two case reports of patients taking appetite suppressants containing fenproporex, illegally imported from Brazil. In the first case, a 26 year-old woman suffered from intermittent chest pains, palpitations, headaches and insomnia for two years. She consulted her doctor numerous times over the two-year period for these unexplained symptoms. Her urine tested positive for amphetamines and benzodiazepines, and both fenproporex and chlordiazepoxide were present in her pills. Her symptoms disappeared after she stopped taking the imported pills.

In the second case, a 38 year-old man tested positive for amphetamines after an occupational urine screening test and was suspended from work. Both fenproporex and fluoxetine were detected in his imported pills. While he was taking the pills he also experienced insomnia and palpitations, symptoms which disappeared after he stopped taking the pills. In both cases, not all the substances detected in the pills matched the ingredients on the vial labels.

Because of the ease of availability of these diet pills over the Internet amongst others, the health and economic consequences of diet pill use are likely to be widespread within certain communities in the US, according to Dr Cohen. He recommends that physicians be made aware of the composition and dangers of the fenproporex-based diet pills imported from South America.

He concludes that "Given the wide variety of potential adverse effects from the medications included in these diet pills, patients attempting to lose weight who experience unexplained symptoms should be specifically questioned regarding the use of imported diet pills."

Reference : Cohen PA (2008). Imported fenproporex-based diet pills from Brazil: a report of two cases.
Journal of General Internal Medicine DOI 10.1007/s11606-008-0878-4

Source: Springer


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4 /5 (1 vote)


January 26, 2009 all stories

Comments: 0

4 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Autism treatment: Risky alternative therapies have little basis in science
    created Nov 24, 2009 | popularity not rated yet | comments 0
  • Tips on hormone use, coping with menopause
    created Oct 26, 2009 | popularity not rated yet | comments 0
  • Lowering blood pressure
    created Oct 16, 2009 | popularity not rated yet | comments 0
  • Study: Exercise improves body image for fit and unfit alike
    created Oct 08, 2009 | popularity not rated yet | comments 0
  • Bristol-Myers gets EU approval for diabetes drug
    created Oct 05, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

eye

Over-the-counter eye drops raise concern over antibiotic resistance

Medicine & Health / Medications

created 2 hours ago | popularity not rated yet | comments 0

(PhysOrg.com) -- The use of antibiotic eye drops for conjunctivitis has increased by almost half since they became available over the counter at chemists in 2005, data obtained by Oxford University researchers ...


Hyperactivity associated with short sleep-time for young boys: study

Hyperactivity associated with short sleep-time for young boys: study

Medicine & Health / Psychology & Psychiatry

created 2 hours ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Hyperactive boys don't get enough sleep, which can worsen their condition according to new research. Published in the November issue of Pediatrics, the study is the first to examine a larg ...


More clarity needed on law of assisted suicide

More clarity needed on law of assisted suicide

Medicine & Health / Other

created 1hour ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Doctors need more clarity on what they can and cannot do within the current law on assisted suicide, according to an editorial by Dr Richard Huxtable and Professor Karen Forbes in this week's ...


School closure could reduce swine flu transmission by 21 percent

Medicine & Health / Diseases

created 3 hours ago | popularity not rated yet | comments 0

A survey carried out in eight European countries has shown that closing schools in the event of an infectious disease pandemic could have a significant role in reducing illness transmission. Researchers writing in the open ...


Diabetes cases to double and costs to triple by 2034

Medicine & Health / Diseases

created 3 hours ago | popularity not rated yet | comments 1

In the next 25 years, the number of Americans living with diabetes will nearly double, increasing from 23.7 million in 2009 to 44.1 million in 2034. Over the same period, spending on diabetes will almost triple, rising from ...